|
⚲
|
| Keyboard |
| Shaan Gandhi | |
|---|---|
| Firm | |
| Address | Vigil Neuroscience, Inc 1 Broadway, 7th Floor, Suite 07300 Cambridge, MA 02142 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Vigil Neuroscience Inc | 021-457309 | Director | 75.0 M of 75.0 M |
||
| Camp4 Therapeutics Corp | 021-449708 | Director | 100.5 M | ||
| Transition Bio Inc | 021-441050 | Director | 39.1 M of 50.0 M |
||
| Garuda Therapeutics Inc | 021-414560 | Director | 48.1 M of 71.8 M |
||
| Dice Molecules Holdings LLC | 021-412563 | Director | 60.0 M of 60.0 M |
||
| Vigil Neuroscience Inc | 021-411167 | Director | 90.0 M of 90.0 M |
||
| Stridebio Inc | 021-393667 | Director | 48.9 M of 81.5 M |
||
| Camp4 Therapeutics Corp | 021-392937 | Director | 45.0 M | ||
| Dice Molecules Holdings LLC | 021-387108 | Director | 54.3 M of 81.5 M |
||
| Vigil Neuroscience Inc | 021-377071 | Director | 50.0 M of 50.0 M |
||